StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

LOVEBearishEarningsnews
High materiality7/10

Lovesac, Avidity Biosciences, Veritone And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Sep 11, 2025, 8:33 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Despite beating EPS expectations, the significant guidance cut and sharp drop in shares reflects negative investor sentiment. Historical context shows similar scenarios have led to further declines.

AI summary

What happened, with direct paths to the underlying reporting

Lovesac's Q2 losses of 45 cents beat expectations of 71 cents. Quarterly sales of $160.53M exceeded estimates of $160.23M. EPS guidance for FY2026 was significantly reduced from $0.80-$1.36 to $0.52-$1.05. Shares tumbled 13% in pre-market trading to $18.05. U.S. stock futures showed small gains with Dow up 0.2%.

  • Lovesac's Q2 losses of 45 cents beat expectations of 71 cents.
  • Quarterly sales of $160.53M exceeded estimates of $160.23M.
  • EPS guidance for FY2026 was significantly reduced from $0.80-$1.36 to $0.52-$1.05.
  • Shares tumbled 13% in pre-market trading to $18.05.
  • U.S. stock futures showed small gains with Dow up 0.2%.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.